Kane Biotech Inc.
KNE.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -42.99% | 244.41% | 37.69% | -38.11% | -45.39% |
| Total Receivables | -7.65% | -28.12% | 131.86% | -89.49% | 81.86% |
| Inventory | -0.77% | 123.81% | -58.06% | -48.71% | -4.18% |
| Prepaid Expenses | -14.40% | -28.10% | 113.91% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 16.97% |
| Total Current Assets | -31.42% | 94.21% | 26.01% | -56.34% | -4.33% |
|
|
|||||
| Total Current Assets | -31.42% | 94.21% | 26.01% | -56.34% | -4.33% |
| Net Property, Plant & Equipment | -42.60% | -0.19% | -2.80% | -9.67% | -2.28% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.42% | 7.54% | 4.29% | -30.77% | 0.96% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -29.59% | 45.75% | 10.60% | -40.03% | -2.88% |
|
|
|||||
| Total Accounts Payable | 16.69% | 13.99% | -19.04% | 59.21% | 38.71% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 1.69% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.41% | 17.86% | 3.12% | -3.29% | 4.34% |
| Total Finance Division Other Current Liabilities | -- | -49.58% | 13.71% | -55.39% | -14.02% |
| Total Other Current Liabilities | -- | -49.58% | 13.71% | -55.39% | -14.02% |
| Total Current Liabilities | -8.29% | -9.13% | -4.43% | -18.02% | -1.70% |
|
|
|||||
| Total Current Liabilities | -8.29% | -9.13% | -4.43% | -18.02% | -1.70% |
| Long-Term Debt | -5.93% | 66.86% | -9.70% | -14.21% | -6.49% |
| Short-term Debt | -- | -- | -- | -- | 1.69% |
| Capital Leases | -49.07% | 0.89% | -3.94% | -9.70% | -2.37% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -14.48% | 9.62% | -5.57% | -15.73% | -2.95% |
|
|
|||||
| Common Stock & APIC | -1.95% | 9.20% | 5.50% | -5.70% | 3.58% |
| Retained Earnings | 0.43% | -6.42% | -3.65% | 3.06% | -3.19% |
| Treasury Stock & Other | -1.89% | 4.95% | -77.90% | -6.16% | -52.58% |
| Total Common Equity | -230.59% | 78.16% | 30.32% | -122.15% | 3.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -230.59% | 78.16% | 30.32% | -122.15% | 3.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -230.59% | 78.16% | 30.32% | -122.15% | 3.34% |
|
|
|||||